Table of Contents
ISRN Gastroenterology
Volume 2014, Article ID 764540, 7 pages
http://dx.doi.org/10.1155/2014/764540
Research Article

Predictors of Mortality among United States Veterans with Human Immunodeficiency Virus and Hepatitis C Virus Coinfection

1Department of Medicine, Division of Hospital Medicine, Weill Cornell Medical College, 525 East 68th Street, P.O. Box 130, New York, NY 10065, USA
2VA Pittsburgh Health Care System, Pittsburgh, PA 15213, USA
3Department of Medicine, Yale School of Medicine, New Haven, CT 06510, USA
4Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
5Department of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, UAE
6Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA

Received 4 January 2014; Accepted 6 February 2014; Published 7 April 2014

Academic Editors: L. Rodrigo and H. Yoshiji

Copyright © 2014 Sebhat Erqou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS, “World AIDS Day Report: The State of AIDS Epidemic,” Tech. Rep., 2011. View at Google Scholar
  2. Center for Disease Control (CDC), “HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas,” Tech. Rep., vol. 23, 2011.
  3. V. Soriano, M. Sulkowski, C. Bergin et al., “Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel,” AIDS, vol. 16, no. 6, pp. 813–828, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. H. K. Monga, M. C. Rodriguez-Barradas, K. Breaux et al., “Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection,” Clinical Infectious Diseases, vol. 33, no. 2, pp. 240–247, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Verucchi, L. Calza, R. Manfredi, and F. Chiodo, “Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management,” Infection, vol. 32, no. 1, pp. 33–46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. R. K. Sterling, E. Lissen, N. Clumeck et al., “Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection,” Hepatology, vol. 43, no. 6, pp. 1317–1325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. T.-Y. Chen, E. L. Ding, G. R. Seage III, and A. Y. Kim, “Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression,” Clinical Infectious Diseases, vol. 49, no. 10, pp. 1605–1615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Martín-Carbonero, V. Soriano, E. Valencia, J. García-Samaniego, M. López, and J. González-Lahoz, “Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients,” AIDS Research and Human Retroviruses, vol. 17, no. 16, pp. 1467–1471, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Soto, A. Sánchez-Quijano, L. Rodrigo et al., “Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis,” Journal of Hepatology, vol. 26, no. 1, pp. 1–5, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Sanchez-Quijano, J. Andreu, F. Gavilan et al., “Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 14, no. 11, pp. 949–953, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Greub, B. Ledergerber, M. Battegay et al., “Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the swiss HIV cohort study,” The Lancet, vol. 356, no. 9244, pp. 1800–1805, 2000. View at Google Scholar · View at Scopus
  12. K. B. Anderson, J. L. Guest, and D. Rimland, “Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA cohort study,” Clinical Infectious Diseases, vol. 39, no. 10, pp. 1507–1513, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Piroth, “Coinfection with hepatitis c virus and HIV: more than double trouble,” Clinical Infectious Diseases, vol. 49, no. 4, pp. 623–625, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. A. Butt, X. Wang, and C. G. Moore, “Effect of hepatitis C virus and its treatment on survival,” Hepatology, vol. 50, no. 2, pp. 387–392, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. A. Butt, A. C. Justice, M. Skanderson, M. O. Rigsby, C. B. Good, and C. K. Kwoh, “Rate and predictors of treatment prescription for hepatitis C,” Gut, vol. 56, no. 3, pp. 385–389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. A. Butt, K. A. McGinnis, M. Skanderson, and A. C. Justice, “Hepatitis C treatment completion rates in routine clinical care,” Liver International, vol. 30, no. 2, pp. 240–250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. A. Butt, U. A. Khan, K. A. McGinnis, M. Skanderson, and C. Kent Kwoh, “Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans,” Journal of Viral Hepatitis, vol. 14, no. 12, pp. 890–896, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. A. Butt, X. Wang, and L. F. Fried, “HCV infection and the incidence of CKD,” The American Journal of Kidney Diseases, vol. 57, no. 3, pp. 396–402, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. A. Butt, K. McGinnis, M. C. Rodriguez-Barradas et al., “HIV infection and the risk of diabetes mellitus,” AIDS, vol. 23, no. 10, pp. 1227–1234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. Fultz, M. Skanderson, L. A. Mole et al., “Development and verification of a “virtual” cohort using the national VA health information system,” Medical Care, vol. 44, no. 8, supplement, pp. S25–S30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. V. L. Re III, J. K. Lim, M. B. Goetz et al., “Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study,” Pharmacoepidemiology and Drug Safety, vol. 20, no. 7, pp. 689–699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. G. Ghany, D. B. Strader, D. L. Thomas, and L. B. Seeff, “Diagnosis, management, and treatment of hepatitis C: an update,” Hepatology, vol. 49, no. 4, pp. 1335–1374, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. E. M. Tedaldi, R. K. Baker, A. C. Moorman et al., “Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy,” Clinical Infectious Diseases, vol. 36, no. 3, pp. 363–367, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Di Martino, P. Rufat, N. Boyer et al., “The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study,” Hepatology, vol. 34, no. 6, pp. 1193–1199, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. M. J. Koziel and M. G. Peters, “Viral hepatitis in HIV infection,” The New England Journal of Medicine, vol. 356, no. 14, pp. 1445–1454, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. A. d'Arminio Monforte, A. Cozzi-Lepri, A. Castagna et al., “Risk of developing specific aids-defining illnesses in patients coinfected with HIV and hepatitis c virus with or without liver cirrhosis,” Clinical Infectious Diseases, vol. 49, no. 4, pp. 612–622, 2009. View at Publisher · View at Google Scholar · View at Scopus